Myoclonus–dystonia syndrome: ε‐sarcoglycan mutations and phenotype
- 29 August 2002
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 52 (4) , 489-492
- https://doi.org/10.1002/ana.10325
Abstract
Mutations in the gene for ε‐sarcoglycan (SGCE) have been found to cause myoclonus‐dystonia syndrome. We now report clinical and genetic findings in nine additional European families with myoclonus‐dystonia syndrome. The clinical presentation in 24 affecteds was homogeneous with myoclonus predominantly of neck and upper limbs in 23 of them and dystonia, presenting as cervical dystonia and/or writer's cramp, in 13 cases. Six novel and one previously known heterozygous SGCE mutations were identified. SGCE deficiency seems to be the common pathogenetic mechanism in myoclonus‐dystonia syndrome.Keywords
This publication has 13 references indexed in Scilit:
- Abnormally spliced β-globin mRNAs: a single point mutation generates transcripts sensitive and insensitive to nonsense-mediated mRNA decayBlood, 2002
- Myoclonus dystoniaNeurology, 2002
- Mutations in the gene encoding ɛ-sarcoglycan cause myoclonus–dystonia syndromeNature Genetics, 2001
- A major locus for several phenotypes of myoclonus–dystonia on chromosome 7qNeurology, 2001
- Inherited myoclonus-dystonia syndrome: Narrowing the 7q21-q31 locus in German familiesAnnals of Neurology, 2001
- The DYT1 phenotype and guidelines for diagnostic testingNeurology, 2000
- Zac1 (Lot1), a Potential Tumor Suppressor Gene, and the Gene for ɛ-Sarcoglycan Are Maternally Imprinted Genes: Identification by a Subtractive Screen of Novel Uniparental Fibroblast LinesMolecular and Cellular Biology, 2000
- Sarcoglycans in muscular dystrophyMicroscopy Research and Technique, 2000
- Localization of a gene for myoclonus-dystonia to chromosome 7q21-q31Annals of Neurology, 1999
- Association of a missense change in the D2 dopamine receptor with myoclonus dystoniaProceedings of the National Academy of Sciences, 1999